Inhibitors | Comment | Organism | Structure |
---|---|---|---|
captopril | i.e. SQ 14225 | Homo sapiens | |
D-Cys-L-Pro | competitive to hippuryl-His-Leu | Homo sapiens | |
EDTA | - |
Homo sapiens | |
L-Cys-L-Pro | - |
Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.071 | - |
angiotensin I | - |
Homo sapiens | |
1 | - |
hippuryl-His-Leu | Tris-NaCl buffer | Homo sapiens | |
3 | - |
hippuryl-His-Leu | phosphosaline buffer | Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
145000 | - |
1 * 145000, enzyme in reduced and unreduced samples, SDS-PAGE | Homo sapiens |
155000 | - |
sucrose density gradient ultracentrifugation | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Purification (Comment) | Organism |
---|---|
- |
Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
serum | - |
Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
- |
Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
angiotensin I + H2O | - |
Homo sapiens | angiotensin II + His-Leu | - |
? | |
bradykinin + H2O | - |
Homo sapiens | Phe-Arg + Ser-Pro + Arg-Pro-Pro-Gly-Phe | - |
? | |
hippuryl-His-Leu + H2O | - |
Homo sapiens | hippuric acid + His-Leu | - |
? | |
p-nitrobenzyloxycarbonyl-Gly-Gly-Gly + H2O | - |
Homo sapiens | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
monomer | 1 * 145000, enzyme in reduced and unreduced samples, SDS-PAGE | Homo sapiens |